ATE269704T1 - Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens - Google Patents

Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens

Info

Publication number
ATE269704T1
ATE269704T1 AT00903994T AT00903994T ATE269704T1 AT E269704 T1 ATE269704 T1 AT E269704T1 AT 00903994 T AT00903994 T AT 00903994T AT 00903994 T AT00903994 T AT 00903994T AT E269704 T1 ATE269704 T1 AT E269704T1
Authority
AT
Austria
Prior art keywords
bond
group
dotted line
hydrogen atom
claudicatio
Prior art date
Application number
AT00903994T
Other languages
English (en)
Inventor
Atsuto Ogata
Norio Inomata
Akira Mizuno
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of ATE269704T1 publication Critical patent/ATE269704T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00903994T 1999-02-17 2000-02-17 Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens ATE269704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3863199 1999-02-17
PCT/JP2000/000883 WO2000048602A1 (en) 1999-02-17 2000-02-17 Intermittent claudication therapeutic drugs comprising pyrroloazepines

Publications (1)

Publication Number Publication Date
ATE269704T1 true ATE269704T1 (de) 2004-07-15

Family

ID=12530599

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00903994T ATE269704T1 (de) 1999-02-17 2000-02-17 Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens

Country Status (13)

Country Link
US (1) US6288056B1 (de)
EP (1) EP1071427B1 (de)
JP (1) JP2002537259A (de)
KR (1) KR20010042658A (de)
CN (1) CN1201740C (de)
AT (1) ATE269704T1 (de)
AU (1) AU2572400A (de)
CA (1) CA2329524A1 (de)
DE (1) DE60011711T2 (de)
ES (1) ES2220396T3 (de)
HU (1) HUP0105469A3 (de)
IL (1) IL139064A0 (de)
WO (1) WO2000048602A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11193290A (ja) 1997-12-26 1999-07-21 Suntory Ltd ピロールスルホンアミド系化合物
KR100677594B1 (ko) * 2005-06-10 2007-02-02 삼성전자주식회사 반도전성 벨트, 그 제조방법, 및 상기 반도전성 벨트를포함하는 전자사진 화상형성장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0525128A (ja) * 1990-05-11 1993-02-02 Suntory Ltd ピロロアゼピン誘導体の製造方法
ES2179218T3 (es) * 1995-12-01 2003-01-16 Suntory Ltd Derivados de pirroloacepina.

Also Published As

Publication number Publication date
HUP0105469A2 (hu) 2002-05-29
JP2002537259A (ja) 2002-11-05
EP1071427A1 (de) 2001-01-31
CA2329524A1 (en) 2000-08-24
HUP0105469A3 (en) 2003-01-28
US6288056B1 (en) 2001-09-11
AU2572400A (en) 2000-09-04
CN1201740C (zh) 2005-05-18
IL139064A0 (en) 2001-11-25
DE60011711D1 (de) 2004-07-29
EP1071427B1 (de) 2004-06-23
WO2000048602A1 (en) 2000-08-24
ES2220396T3 (es) 2004-12-16
DE60011711T2 (de) 2005-07-07
CN1297351A (zh) 2001-05-30
KR20010042658A (ko) 2001-05-25

Similar Documents

Publication Publication Date Title
BG103945A (bg) Производни на 4"-заместен-9-деоксо-9а-аза-9а- хомоеритромицин а
EA200300354A1 (ru) Хинолиноновые производные в качестве ингибиторов тирозинкиназы
ATE273958T1 (de) Heterocyclische verbindungen als h+-atpasen
BR0109703A (pt) Derivados de piperazina
GEP20053602B (en) Aripiprazole for Oral Administration
UY25679A1 (es) Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
NZ527123A (en) Oxazolyl-pyrazole derivatives as kinase inhibitors
ATE264852T1 (de) Chinolinderivate als antibakterielle mittel
MXPA02011458A (es) Derivados de acilfenilurea, metodos para su produccion y uso de los mismos como farmacos.
TR200103525T2 (tr) Bisiklik poliaminosit metal kompleksleri, bunları hazırlamak için yöntem ve bunların tıbbi görüntülemede kullanımı.
AU2002314914A1 (en) Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
ATE302778T1 (de) N-substituierte 4-aminopteridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
SE9903894D0 (sv) Novel compounds
BR0012032A (pt) Derivado do grupo a de estreptograminas, processo de preparação do mesmo, e composição farmacêutica
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE60123117D1 (de) Verwendung von alpha-halogenacryloyl-distamycin derivaten zur herstellung eines medikaments zur behandlung von krebs
DE60011711D1 (de) Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
SE0004462D0 (sv) Novel method and use
ATE421961T1 (de) Piperidinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzung zur behandlung von alzheimer-krankheit, die diese derivate enthält
GEP20032928B (en) Halo Derivatives of 9-Deoxo-9a-Aza-9a-Homerythromycin A, Method for its Production, Pharmaceutical Compositions Containing the Same and Their Use for Treatment or Prevention of Bacterial Infections
AR023282A1 (es) Derivados de higromicina
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties